Preventive healthcare utilisation among adults eligible for lung cancer screening
A recent study published in JAMA on 3 April 2025, titled “Preventive Health Care Use…
Author Rachael Babin
Rachael Babin
Rachael Babin is a medical writer, communications expert, digital content producer and trained media host. Rachael co-founded The Oncology Network in 2014. She is Editor-in-Chief of Oncology News Australia, Publisher of The Oncology Newsletter and Host and Creator of The Oncology Podcast. Before creating The Oncology Network, Rachael worked for MOGA, COSA and an international academic publishing house.
Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis
A recent study published in JAMA investigates the efficacy of high-resolution microultrasonography (microUS)-guided biopsy compared…
Microplastics in intravenous infusions: emerging health concerns for medical practitioners
Recent research has uncovered a significant pathway for microplastic (MP) entry into the human body:…
Interval breast cancer: understanding risks and the need for enhanced screening
Breast cancer screening through mammography has long been a cornerstone of early detection and mortality…
Prostate cancer and erectile function: NeuroSAFE technique enhances postoperative outcomes in robot-assisted radical prostatectomy
A recent phase 3 trial published in The Lancet Oncology has demonstrated that the NeuroSAFE…
No added benefit of atezolizumab in post-surgical treatment of early-stage triple-negative breast cancer
A ground breaking international clinical trial published in JAMA has found that adding the immunotherapy…
Should alcoholic drinks have cancer warning labels?
A recent article in JAMA, “Drinking Alcohol Causes Certain Cancers, So Why Don’t Labels Warn…
Pembrolizumab shows promise in treating advanced clear cell gynaecological cancers: phase 2 trial results
A phase 2 non-randomised clinical trial has demonstrated the potential benefits of pembrolizumab in patients…
Tumour-infiltrating lymphocytes as a prognostic biomarker in early ERBB2-positive breast cancer: a decade-long study offers new insights
A decade-long follow-up from the ShortHER randomised clinical trial suggests that tumour-infiltrating lymphocytes (TILs) could…
Endocrine therapy interruption and resumption in pregnancy-associated breast cancer: real-world outcomes highlight gaps in care
A new study examining the real-world implications of interrupting endocrine therapy (ET) for pregnancy in…